What is the primary goal of active immunotherapy?

The primary goal of active immunotherapy is to mount an immune response against tumor cells. Active immunotherapy works by stimulating the immune system to recognize and attack cancer cells more effectively. This approach enhances the body’s natural defenses, enabling it to identify and destroy malignant cells that might otherwise evade detection.

In contrast to other options, which suggest harmful outcomes or do not align with the principles of immunotherapy, the focus on eliciting an immune response is a core component of this treatment modality. Active immunotherapy can utilize various strategies, such as vaccines or immune checkpoint inhibitors, to enhance the body’s ability to combat cancer. By facilitating a robust immune response specifically targeting tumor-associated antigens, this treatment aims to reduce tumor growth or prevent recurrence, making it a central strategy in modern oncology.